ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+25.71%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$123M
AUM Growth
+$4.83M
Cap. Flow
-$14.4M
Cap. Flow %
-11.67%
Top 10 Hldgs %
61.58%
Holding
49
New
16
Increased
11
Reduced
12
Closed
7

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$3.14M
2
PCVX icon
Vaxcyte
PCVX
$2.86M
3
INSM icon
Insmed
INSM
$2.58M
4
CMPS
Compass Pathways
CMPS
$2.43M
5
MREO
Mereo BioPharma
MREO
$2.4M

Top Sells

1
OCUL icon
Ocular Therapeutix
OCUL
$13.8M
2
PRAX icon
Praxis Precision Medicines
PRAX
$6.15M
3
DYN icon
Dyne Therapeutics
DYN
$5.97M
4
SRPT icon
Sarepta Therapeutics
SRPT
$4.35M
5
AGIO icon
Agios Pharmaceuticals
AGIO
$3.39M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TRVI icon
26
Trevi Therapeutics
TRVI
$854M
$970K 0.79%
290,500
+30,500
+12% +$102K
UNCY icon
27
Unicycive Therapeutics
UNCY
$77M
$807K 0.65%
+197,920
New +$807K
LQDA icon
28
Liquidia Corp
LQDA
$2.48B
$735K 0.6%
+73,500
New +$735K
VERV
29
DELISTED
Verve Therapeutics
VERV
$707K 0.57%
+146,100
New +$707K
GERN icon
30
Geron
GERN
$893M
$703K 0.57%
+154,900
New +$703K
CELC icon
31
Celcuity
CELC
$2.36B
$695K 0.56%
46,600
+1,600
+4% +$23.9K
ARTV
32
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$88.2M
$680K 0.55%
+44,000
New +$680K
TECX
33
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
$415K 0.34%
+13,700
New +$415K
CRBP icon
34
Corbus Pharmaceuticals
CRBP
$121M
$382K 0.31%
18,500
-46,000
-71% -$949K
RAPP
35
Rapport Therapeutics
RAPP
$524M
$360K 0.29%
17,600
-2,400
-12% -$49.2K
LPTX icon
36
Leap Therapeutics
LPTX
$11.7M
$310K 0.25%
120,500
-74,500
-38% -$191K
CLYM
37
Climb Bio, Inc. Common Stock
CLYM
$162M
$275K 0.22%
+54,000
New +$275K
BNTC icon
38
Benitec Biopharma
BNTC
$365M
$274K 0.22%
+29,800
New +$274K
TVTX icon
39
Travere Therapeutics
TVTX
$1.93B
$266K 0.22%
+19,000
New +$266K
THRD
40
DELISTED
Third Harmonic Bio
THRD
$210K 0.17%
+15,508
New +$210K
NUVB.WS icon
41
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$8.89K 0.01%
90,832
– –
AGIO icon
42
Agios Pharmaceuticals
AGIO
$2.09B
– –
-78,700
Closed -$3.39M
CLRB icon
43
Cellectar Biosciences
CLRB
$15.9M
– –
-2,350
Closed -$176K
ORIC icon
44
Oric Pharmaceuticals
ORIC
$1.06B
– –
-96,000
Closed -$679K
PLRX icon
45
Pliant Therapeutics
PLRX
$114M
– –
-46,200
Closed -$497K
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.96B
– –
-27,500
Closed -$4.35M
SVRA icon
47
Savara
SVRA
$643M
– –
0
– –
VRDN icon
48
Viridian Therapeutics
VRDN
$1.53B
– –
-199,433
Closed -$2.59M
NAMS icon
49
NewAmsterdam Pharma
NAMS
$3.04B
– –
-22,500
Closed -$432K
1
2